---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-009894"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T19:37:59.075909+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PAVmed extends senior secured note maturities to 2025; pays $2M for covenant waiver

## Summary
- April 2022 Note maturity extended to April 4, 2025; September 2022 Note to September 8, 2025.
- Holder waived financial covenant (30% market cap to principal ratio) from Dec 1 2023 to Aug 31 2024.
- PAVmed to pay $2M cash (or agreed form) by April 25, 2024 for the amendment and waiver.
- Covenant waiver conditioned on company market capitalization not falling below $75M during period.

## SEC filing metadata
- accession: 0001493152-24-009894
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315224009894/0001493152-24-009894-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315224009894/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-009894
- JSON: https://secwatch.observer/filing/0001493152-24-009894.json
- Plain text: https://secwatch.observer/filing/0001493152-24-009894.txt

## Key facts
- Material Agreements
  PAVmed Inc. amended Amendment and Waiver with holder of senior secured convertible notes valued at $2,000,000 cash payment; maturity extended to April 4, 2025 (April 2022 Note) and September 8, 2025 (effective 2024-03-12).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: holder of senior secured convertible notes
  - Value: $2,000,000 cash payment; maturity extended to April 4, 2025 (April 2022 Note) and September 8, 2025
  - Effective: 2024-03-12
  source text: Effective as of March 12, 2024, PAVmed Inc. (the “ Company ”), entered into an amendment and waiver (the “ Amendment and Waiver ”) with the holder of the senior secured convertible note issued by the Company as of April 4, 2022 (the “ April 2022 Note ”) and the secured convertible note issued by the Company as of September 8, 2022 (the “ September 2022 Note ,” and together with the April 2022 Note, the “ Notes ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1624326/000149315224009894/0001493152-24-009894-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.